BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7446129)

  • 21. Functional and phenotypic characteristics of effusion-associated lymphoid cells cultured in the presence of either recombinant interleukin 2 or T-cell growth factor from malignant pleural and peritoneal effusions in patients with advanced carcinoma.
    Ebihara T; Koyama S
    Tohoku J Exp Med; 1990 Sep; 162(1):49-63. PubMed ID: 2077678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro kinetics of functional parameters of macrophage activation with lymphokines and its relation to tumor cell cytostasis.
    Matsunaga K; Mashiba H
    Jpn J Exp Med; 1981 Oct; 51(5):287-92. PubMed ID: 7321254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential in vitro modulation of suppressor and antitumor functions of mouse macrophages by lymphokines and/or endotoxin.
    Chang ZL; Bonvini E; Varesio L; Holden HT; Herberman RB
    Cell Immunol; 1988 Jul; 114(2):282-92. PubMed ID: 2839302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further analysis of the anti-tumour effect in vitro of peritoneal exudate cells from mice treated with Corynebacterium parvum.
    Ghaffar A; Cullen RT; Woodruff MA
    Br J Cancer; 1975 Jan; 31(1):15-24. PubMed ID: 1156505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-cytotoxic activity of resident rat macrophages.
    Johnson WJ; Balish E
    J Reticuloendothel Soc; 1981 May; 29(5):369-79. PubMed ID: 7241409
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of Corynebacterium parvum in the activation of peritoneal macrophages. II. Identification of distinguishable anti-tumor activities by macrophage subpopulations.
    Chapes SK; Haskill S
    Cell Immunol; 1983 Feb; 76(1):49-57. PubMed ID: 6219754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Corynebacterium parvum on Escherichia coli infection in mice.
    Yoshikai Y; Miake S; Mituyama M; Nomoto K
    J Gen Microbiol; 1982 Dec; 128(12):2857-63. PubMed ID: 6763935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytostatic activity of in vitro generated macrophages: evidence for a prostaglandin-independent reversible cytostatic mechanism.
    Stout RD
    Cell Immunol; 1985 Nov; 96(1):83-103. PubMed ID: 2424622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Divergent expression of cytotoxic and microbicidal functions of rabbit alveolar and peritoneal macrophages: effects of non-specific activation and a natural microbicidal peptide, MCP-1.
    Sorrell TC; Lehrer RI; Ferrari LG; Müller M; Selsted ME
    Aust J Exp Biol Med Sci; 1985 Feb; 63 ( Pt 1)():53-63. PubMed ID: 3893405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulatory effect of killed Propionibacterium acnes and its purified soluble polysaccharide on peritoneal exudate cells from C57Bl/6 mice: major NKT cell recruitment and increased cytotoxicity.
    Ananias RZ; Rodrigues EG; Braga EG; Squaiella CC; Mussalem JS; Longhini AL; Travassos LR; Longo-Maugéri IM
    Scand J Immunol; 2007 Jun; 65(6):538-48. PubMed ID: 17523946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of macrophage activation by Corynebacterium parvum. I. In vitro experiments.
    Christie GH; Bomford R
    Cell Immunol; 1975 May; 17(1):141-9. PubMed ID: 1092470
    [No Abstract]   [Full Text] [Related]  

  • 32. Macrophage stimulation by bacterial lipopolysaccharides. I. Cytolytic effect on tumor target cells.
    Doe WF; Henson PM
    J Exp Med; 1978 Aug; 148(2):544-56. PubMed ID: 568163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody-dependent and -independent cytotoxicity of human mononuclear phagocytes: defective stimulation of tumoricidal activity in milk macrophages.
    Biondi A; Peri G; Colombo N; Bolis G; Mantovani A
    Clin Exp Immunol; 1982 Sep; 49(3):701-8. PubMed ID: 7172502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophages from malignant effusions.
    Katz DR
    J Pathol; 1981 Aug; 134(4):279-90. PubMed ID: 7320810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Separation of functionally distinct subpopulations of Corynebacterium parvum-activated macrophages with predominantly stimulatory or suppressive effect on the cell-mediated cytotoxic T cell response.
    Lee KC; Kay J; Wong M
    Cell Immunol; 1979 Jan; 42(1):28-41. PubMed ID: 312146
    [No Abstract]   [Full Text] [Related]  

  • 36. Two anti-tumour cytotoxic cells in the peritoneal cavity of rats: natural occurrence, augmentation and partial characterization.
    Inoue Y; Nelson DS
    Aust J Exp Biol Med Sci; 1982 Feb; 60(Pt 1):41-53. PubMed ID: 7092732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the in-vitro antitumor activity of peritoneal cells from mice injected with Corynebacterium parvum and Corynebacterium liquefaciens.
    Toge T; Hattori T
    Hiroshima J Med Sci; 1979 Jun; 28(2):95-101. PubMed ID: 478988
    [No Abstract]   [Full Text] [Related]  

  • 38. Rejection of murine ovarian cancer following treatment with regional immunotherapy: correlations with a neutrophil-mediated activation of cytostatic macrophages.
    Lichtenstein A
    Cell Immunol; 1985 Sep; 94(2):521-35. PubMed ID: 4028167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Corynebacterium parvum treatment and Toxoplasma gondii infection on macrophage-mediated cytostasis of tumour target cells.
    Krahenbuhl JL; Lambert LH; Remington JS
    Immunology; 1976 Dec; 31(6):837-46. PubMed ID: 992714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1979 Apr; 122(4):1587-91. PubMed ID: 376720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.